Endogenous Gal9 has been implicated in prevention of malignant tumour progression through disruption of CD44-hyaluronan interactions33, acting as a potent IgE antagonist preventing degranulation of mast cells34 and as an inducer of immunosuppressive macrophages which ameliorate T cell-driven inflammation35. This evidence concerns the gene LGALS9 and cancer.